切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2021, Vol. 15 ›› Issue (04) : 242 -246. doi: 10.3877/cma.j.issn.1674-0807.2021.04.010

所属专题: 文献

综述

生物电阻抗在乳腺癌术后上肢淋巴水肿诊断中的应用
刘思尧1, 刘淼1, 王殊1,()   
  1. 1. 100044 北京大学人民医院乳腺中心
  • 收稿日期:2019-02-22 出版日期:2021-09-08
  • 通信作者: 王殊

Bioimpedance in the diagnosis of upper limb lymphedema after breast cancer surgery

Siyao Liu1, Miao Liu1, Shu Wang1()   

  • Received:2019-02-22 Published:2021-09-08
  • Corresponding author: Shu Wang
引用本文:

刘思尧, 刘淼, 王殊. 生物电阻抗在乳腺癌术后上肢淋巴水肿诊断中的应用[J]. 中华乳腺病杂志(电子版), 2021, 15(04): 242-246.

Siyao Liu, Miao Liu, Shu Wang. Bioimpedance in the diagnosis of upper limb lymphedema after breast cancer surgery[J]. Chinese Journal of Breast Disease(Electronic Edition), 2021, 15(04): 242-246.

乳腺癌治疗的进步使得患者对术后生活质量有了更高的要求,而术后上肢淋巴水肿对患者的危害日益突出,寻找有效的早期筛查淋巴水肿的工具至关重要。笔者通过回顾既往有关生物电阻抗在乳腺癌术后上肢淋巴水肿诊断方面的研究,发现生物电阻抗能准确诊断已经存在的乳腺癌术后上肢淋巴水肿,相比于臂围测量、肢体体积测量、远红外测量和主观症状评分等方法,它对于亚临床阶段的淋巴水肿有更好的诊断价值。

表1 生物电阻抗对比臂围测量法诊断淋巴水肿的研究
表2 生物电阻抗对比排水法诊断淋巴水肿的研究
表3 生物电阻抗对比Perometer法诊断淋巴水肿的研究
表4 生物电阻抗对比多种淋巴水肿检测方法的研究
[1]
Vignes S, Fau-Prudhomot P, Simon L, et al. Impact of breast cancer-related lymphedema on working women [J]. Suppor Care Cancer, 2019, 28(1): 79-85.
[2]
Giray E, Akyuz G. Assessment of family caregiver burden and its relationships between quality of life, arm disability, grip strength, and lymphedema symptoms in women with postmastectomy lymphedema: a prospective cross-sectional study [J]. Eur J Breast Health, 2019, 15(2): 111-118.
[3]
Levenhagen K, Davies C, Perdomo M, et al. Diagnosis of upper quadrant lymphedema secondary to cancer: clinical practice guideline from the Oncology Section of the American Physical Therapy Association [J]. Phys Ther, 2017, 97(7): 729-745.
[4]
Ammitzboll G, Johansen C, Lanng C, et al. Progressive resistance training to prevent arm lymphedema in the first year after breast cancer surgery: Results of a randomized controlled trial [J]. Cancer, 2019, 125(10): 1683-1692.
[5]
Tandra P, Kallam A, Krishnamurthy J. Identification and management of lymphedema in patients with breast cancer [J]. J Oncol Pract, 2019, 15(5): 255-262.
[6]
Shi S, Lu Q, Fu MR, et al. Psychometric properties of the breast cancer and lymphedema symptom experience index: the Chinese version [J]. Eur J Oncol Nurs, 2016, 20: 10-16.
[7]
Fu MR, Axelrod D, Cleland CM, et al. Symptom report in detecting breast cancer-related lymphedema [J]. Breast Cancer (Dove Med Press), 2015, 7: 345-352.
[8]
Yamamoto T, Yamamoto N, Doi K, et al. Indocyanine green-enhanced lymphography for upper extremity lymphedema: a novel severity staging system using dermal backflow patterns[J]. Plast Reconstr Surg, 2011, 128(4): 941-947.
[9]
Shah C, Vicini FA, Arthur D. Bioimpedance spectroscopy for breast cancer related lymphedema assessment: clinical practice guidelines [J]. Breast J, 2016, 22(6): 645-650.
[10]
Shah C, Arthur DW, Wazer D, et al. The impact of early detection and intervention of breast cancer-related lymphedema: a systematic review [J]. Cancer Med, 2016, 5(6): 1154-1162.
[11]
Seward C, Skolny M, Brunelle C, et al. A comprehensive review of bioimpedance spectroscopy as a diagnostic tool for the detection and measurement of breast cancer-related lymphedema [J]. J Surg Oncol, 2016, 114(5): 537-542.
[12]
Engin O, Akalin E, Saribay E, et al. Easy volumeter in detection of breast cancer-related lymphedema: a validity study [J]. Lymphat Res Biol, 2019, 17(5): 543-549.
[13]
Soran A, Ozmen T, McGuire KP, et al. The importance of detection of subclinical lymphedema for the prevention of breast cancer-related clinical lymphedema after axillary lymph node dissection; a prospective observational study [J]. Lymphat Res Biol, 2014, 12(4): 289-294.
[14]
Hayes S, Cornish B, Newman B. Comparison of methods to diagnose lymphoedema among breast cancer survivors: 6-month follow-up [J]. Breast Cancer Res Treat, 2005, 89(3): 221-226.
[15]
Hayes S, Di Sipio T, Rye S, et al. Prevalence and prognostic significance of secondary lymphedema following breast cancer [J]. Lymphat Res Biol, 2011, 9(3): 135-141.
[16]
Cornish BH, Thomas BJ, Ward LC, et al. A new technique for the quantification of peripheral oedema; with application in both unilateral and bilateral cases [J]. Angiology, 2002, 53(1): 41-47.
[17]
徐舒曼,陈莉. 乳腺癌相关淋巴水肿的治疗进展 [J/CD]. 中华乳腺病杂志(电子版), 2017, 11(4): 247-251.
[18]
Sun F, Skolny MN, Swaroop MN, et al. The need for preoperative baseline arm measurement to accurately quantify breast cancer-related lymphedema [J]. Breast Cancer Res Treat, 2016, 157(2): 229-240.
[19]
Sun F, Hall A, Tighe MP, et al. Perometry versus simulated circumferential tape measurement for the detection of breast cancer-related lymphedema [J]. Breast Cancer Res Treat, 2018, 172(1): 83-91.
[20]
Asdourian MS, Skolny MN, Brunelle C, et al. Precautions for breast cancer-related lymphoedema: risk from air travel, ipsilateral arm blood pressure measurements, skin puncture, extreme temperatures, and cellulitis [J]. Lancet Oncol, 2016, 17(9): e392-405.
[21]
Penha TR, Botter B, Heuts EM, et al. Quality of life in patients with breast cancer-related lymphedema and reconstructive breast surgery [J]. J Reconstr Microsurg, 2016, 32(6): 484-490.
[22]
Kim P, Lee JK, Lim OK, et al. Quantitative lymphoscintigraphy to predict the possibility of lymphedema development after breast cancer surgery: retrospective clinical study [J]. Ann Rehabil Med, 2017, 41(6): 1065-1075.
[23]
Cheng MH, Pappalardo M, Lin C, et al. Validity of the novel Taiwan lymphoscintigraphy staging and correlation of Cheng lymphedema grading for unilateral extremity lymphedema [J]. Ann Surg, 2018, 268(3): 513-525.
[24]
Akita S, Nakamura R, Yamamoto N, et al. Early detection of lymphatic disorder and treatment for lymphedema following breast cancer [J]. Plast Reconstr Surg, 2016, 138(2): 192e-202e.
[25]
Czerniec SA, Ward LC, Refshauge KM, et al. Assessment of breast cancer-related arm lymphedema--comparison of physical measurement methods and self-report [J]. Cancer Invest, 2010, 28(1): 54-62.
[26]
沈莉,谢娜,王鹤玮,等. 生物电阻抗早期监测乳腺癌术后上肢淋巴水肿的敏感性与特异性研究 [J]. 中国康复医学杂志2018, 33(04): 405-408.
[27]
Ward LC, Bunce IH, Cornish BH, et al. Multi-frequency bioelectrical impedance augments the diagnosis and management of lymphoedema in post-mastectomy patients [J]. Eur J Clin Invest, 1992, 22(11): 751-754.
[28]
Cornish BH, Chapman M, Hirst C, et al. Early diagnosis of lymphedema using multiple frequency bioimpedance [J]. Lymphology, 2001, 34(1): 2-11.
[29]
Dylke ES, Ward LC. Three decades of bioelectrical Impedance spectroscopy in lymphedema assessment: an historical perspective[J]. Lymphat Res Biol202119(3):206-214.
[30]
Fu MR, Cleland CM, Guth AA, et al. L-dex ratio in detecting breast cancer-related lymphedema: reliability, sensitivity, and specificity [J]. Lymphology, 2013, 46(2): 85-96.
[31]
Box RC, Reul-Hirche HM, Bullock-Saxton JE, et al. Physiotherapy after breast cancer surgery: results of a randomised controlled study to minimise lymphoedema [J]. Breast Cancer Res Treat, 2002, 75(1): 51-64.
[32]
Smoot BJ, Wong JF, Dodd MJ. Comparison of diagnostic accuracy of clinical measures of breast cancer-related lymphedema: area under the curve [J]. Arch Phys Med Rehabil, 2011, 92(4): 603-610.
[33]
Soran A, Menekse E, Girgis M, et al. Breast cancer-related lymphedema after axillary lymph node dissection: does early postoperative prediction model work? [J]. Support Care Cancer, 201624(3):1413-1419.
[34]
Barrio AV, Eaton A, Frazier TG. A prospective validation study of bioimpedance with volume displacement in early-stage breast cancer patients at risk for lymphedema [J]. Ann Surg Oncol, 2015, 22 Suppl 3: S370-375.
[35]
Ward LC, Czerniec S, Kilbreath SL. Operational equivalence of bioimpedance indices and perometry for the assessment of unilateral arm lymphedema [J]. Lymphat Res Biol, 2009, 7(2): 81-85.
[36]
Ward LC, Czerniec S, Kilbreath SL. Quantitative bioimpedance spectroscopy for the assessment of lymphoedema [J]. Breast Cancer Res Treat, 2009, 117(3): 541-547.
[37]
Czerniec SA, Ward LC, Lee MJ, et al. Segmental measurement of breast cancer-related arm lymphoedema using perometry and bioimpedance spectroscopy [J]. Support Care Cancer, 2010, 19(5): 703-710.
[38]
Bundred NJ, Stockton C, Keeley V, et al. Comparison of multi-frequency bioimpedance with perometry for the early detection and intervention of lymphoedema after axillary node clearance for breast cancer [J]. Breast Cancer Res Treat, 2015, 151(1): 121-129.
[39]
Qin ES, Bowen MJ, Chen WF. Diagnostic accuracy of bioimpedance spectroscopy in patients with lymphedema: A retrospective cohort analysis [J]. J Plast Reconstr Aesthet Surg, 2018, 71(7): 1041-1050.
[40]
Executive C. The diagnosis and treatment of peripheral lymphedema: 2016 consensus document of the International Society of Lymphology [J]. Lymphology, 2016, 49(4): 170-184.
[41]
McLaughlin SA, Staley AC, Vicini F, et al. Considerations for clinicians in the diagnosis, prevention, and treatment of breast cancer-related lymphedema: recommendations from a multidisciplinary expert ASBrS panel: Part 1: definitions, assessments, education, and future directions [J]. Ann Surg Oncol, 2017, 24(10): 2818-2826.
[42]
Koelmeyer LA, Borotkanics RJ, Alcorso J, et al. Early surveillance is associated with less incidence and severity of breast cancer-related lymphedema compared with a traditional referral model of care [J]. Cancer, 2019, 125(6): 854-862.
[1] 郏亚平, 曾书娥. 含鳞状细胞癌成分的乳腺化生性癌的超声与病理特征分析[J]. 中华医学超声杂志(电子版), 2023, 20(08): 844-848.
[2] 唐玮, 何融泉, 黄素宁. 深度学习在乳腺癌影像诊疗和预后预测中的应用[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 323-328.
[3] 康夏, 田浩, 钱进, 高源, 缪洪明, 齐晓伟. 骨织素抑制破骨细胞分化改善肿瘤骨转移中骨溶解的机制研究[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 329-339.
[4] 衣晓丽, 胡沙沙, 张彦. HER-2低表达对乳腺癌新辅助治疗疗效及预后的影响[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 340-346.
[5] 施杰, 李云涛, 高海燕. 腋窝淋巴结阳性Luminal A型乳腺癌患者新辅助与辅助化疗的预后及影响因素分析[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 353-361.
[6] 伍秋苑, 陈佩贤, 邓裕华, 何添成, 周丹. 肠道微生物在乳腺癌中的研究进展[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 362-365.
[7] 谭巧, 苏小涵, 侯令密, 黎君彦, 邓世山. 乳腺髓样癌的诊治进展[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 366-368.
[8] 周婉丽, 钱铮, 李喆. 槐耳在乳腺癌免疫治疗中的研究进展[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 369-371.
[9] 熊倩, 罗凤. 乳腺癌患者术后康复现状与对策的研究进展[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 372-374.
[10] 杨小菁, 姜瑞瑞, 石玉香, 王静静, 李长天. 乳腺孤立性纤维性肿瘤一例[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 375-377.
[11] 冯雪园, 韩萌萌, 马宁. 乳腺原发上皮样血管内皮瘤一例[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 378-380.
[12] 康一坤, 袁芃. 三阴性乳腺癌分子遗传学及临床特征研究进展[J]. 中华乳腺病杂志(电子版), 2023, 17(05): 290-293.
[13] 王雪菲, 海琳悦, 李立方, 肖春花. Luminal A型乳腺癌的内分泌治疗与化疗[J]. 中华乳腺病杂志(电子版), 2023, 17(05): 294-300.
[14] 晏晴艳, 雍晓梅, 罗洪, 杜敏. 成都地区老年转移性乳腺癌的预后及生存因素研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 636-638.
[15] 李智铭, 郭晨明, 庄晓晨, 候雪琴, 高军喜. 早期乳腺癌超声造影定性及定量指标的对比研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 639-643.
阅读次数
全文


摘要